New MIT Nanotech Fights Cancer Naturally
September 20, 2010 8:30 AM
comment(s) - last by
Harnessing the body's own defense forces to fight cancer with nanoscale technology.
In the myriad advances in treating cancer, many a nanotech study has crossed
path. This week another such study was revealed by the journal
(abstract). In the past, we’ve seen all sorts of man-made nanoparticles both acting as a force of cell destruction and as a ferry, shipping anti-tumor drugs straight to cancer cells where they can be of the most benefit. This latest method by Massachusetts Institute of Technology researchers is akin to the latter, but instead of using nanoparticles to deliver drugs, they deliver modified immune cells from the patient’s own body.
Dr. Darrell Irvine, the team leader for the MIT study, spoke optimistically of the new treatment. “What we're looking for is the extra nudge that could take immune-cell therapy from working in a subset of people to working in nearly all patients, and to take us closer to cures of disease rather than slowing progression.”
The process by which the treatment is administered
. T cells, a type of white blood cell which is involved in cell-mediated immunity, are harvested from the patient’s blood. They are then treated in such a way so that they specifically target cancer cells. The new T cells are then attached to a lipid-based nanoparticle filled with interleukins. Interleukins are a type of chemical that helps promote the growth of T cells. Finally, the T cell and interleukin-laden nanoparticles are injected back into the patient, where the T cells seek out the tumors they’ve been programmed to destroy. The interleukins help maintain a healthy T cell count to combat the cancer cells directly without causing aberrant production elsewhere in the body.
The final part here is important. Interleukin treatments have already been widely tested in cancer patients to promote cancer-fighting T cell growth, but the treatments can have devastating side effects including heart and lung failure. The targeted approach used by Irvine’s group holds the runaway T cell production process in check by only allowing those at the tumor’s area to be affected.
In a trial using mice, the treatment was found to be 100% effective. While standard T cell or T cell and interleukin treatment mice died after 75 days, the control mice died after only 25 days and the mice given the nanoparticle treatment lived on past the 100 day limit of the study.
This article is over a month old, voting and posting comments is disabled
Such a way
9/20/2010 9:17:09 AM
Don’t get me wrong I am all for Simplicity and such but "They are then treated in such a way so that they specifically target cancer cells." That "such a way" should be better explained because that’s main thing in this article. Exceptions; talking to children under 13 and proprietary secrets.
RE: Such a way
9/20/2010 12:22:59 PM
Actually, no. The main thing is the removal of the devastating side effects. The programming has been done already in the past, so its not news.
RE: Such a way
9/20/2010 2:33:31 PM
"They are treated in such a way so that they specifically target cancer cells".
"They specifically target cancer cells!" before they did havoc in heart and lungs and other organs similar or close to chemotherapy
I am interested to know how they made those modified blood cells, target specific illness.
I think this is main and most important news in the article and should be explained.
“So far we have not seen a single Android device that does not infringe on our patents." -- Microsoft General Counsel Brad Smith
Microsoft Co-founder Paul Allen Donates $100M to Fight Raging Ebola Epidemic
October 23, 2014, 6:05 PM
Cool Science Video of the Day: Carnivorous Leech Eats Giant Jungle Worm
October 16, 2014, 6:44 PM
Facebook CEO and Founder, Mark Zuckerberg, Donates $25M to Fight Ebola
October 14, 2014, 5:06 PM
Chagrined Over Leaks, CDC Confirms First U.S. Ebola Diagnosis in Dallas, Texas
September 30, 2014, 5:55 PM
Nail Polish May Soon be Able to Detect Date Rape Drugs
August 26, 2014, 7:57 AM
SpaceX Falcon 9-R Rocket Suffers Malfunction, Self-Destructs During Test Flight
August 23, 2014, 9:36 AM
Most Popular Articles
Amid Theater Boycott Netflix Defiantly Plans New Movies, Plus 3 TV Shows for 2015
October 24, 2014, 7:30 PM
AT&T Defeats Purpose of New Apple SIM, Locks iPad Air 2 SIMs to Its Network
October 24, 2014, 2:17 PM
CVS, Rite Aid Kill Unofficial Apple Pay Support, Burn Google Wallet Users in the Process
October 25, 2014, 5:26 PM
1 Million Credit Card Activated on Apple Pay Within 72 Hours, Walmart CEO Hopes Visa "Suffers"
October 28, 2014, 8:17 AM
Microsoft's Figures Show Desktop Users Flocking to Windows 10 Preview
October 27, 2014, 11:04 AM
Latest Blog Posts
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
Space Terrorism is a Looming Threat For the United States
Apr 23, 2014, 7:47 PM
More Blog Posts
Copyright 2014 DailyTech LLC. -
Terms, Conditions & Privacy Information